← Back to Patent Explorer
US4439421A Expired / Lapsed US ⏱️ 0.0 years remaining

Stabilized gamma globulin concentrate

Assignee: Baxter International Inc
•
Filing: 1982-08-30
•
Granted: 1984-03-27
•
Expires: 2002-08-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Gamma globulin concentrates are stabilized against anticomplement activity generation during lyophilization by inclusion in the concentrate of a physiologically acceptable, substantially nonsurface-active hydrophilic macromolecule. The improved concentrates may be safely administered to patients. The main additives to the gamma globulin are a substantially nonsurface-active hydrophilic macromolecule, a protein and a polyol.

Inventors

  • 👤 John A. Hooper
  • 👤 Samia Mankarious
  • 👤 Catherine R. Liu-Rash

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 15:53
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/06; C07K16/065; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 29
Claim 1
Independent Claim 97 words
A stabilized gamma globulin concentrate comprising gamma globulin (a) a water soluble, physiologically acceptable, substantially nonsurface-active hydrophilic macromolecule having a molecular weight greater than about 1000 Daltons, (b) a water soluble, physiologically acceptable protein other than gamma globulin and (c) a water soluble, physiologically acceptable polyol having a molecular weight less than the average molecular weight of the hydrophilic macromolecule, said macromolecule, protein and polyol being present, respectively, in a weight ratio to total protein in the concentrate of (a) about from 0.0075:1 to 0.062:1, (b) about from 0.01:1 to 0.125:1 and (c) about from 0.05:1 1.25:1.
Claim 2
Dependent Claim 97 words
A stabilized gamma globulin concentrate comprising gamma globulin (a) a water soluble, physiologically acceptable, substantially nonsurface-active hydrophilic macromolecule having a molecular weight greater than about 1000 Daltons, (b) a water soluble, physiologically acceptable protein other than gamma globulin and (c) a water soluble, physiologically acceptable polyol having a molecular weight less than the average molecular weight of the hydrophilic macromolecule, said macromolecule, protein and polyol being present, respectively, in a weight ratio to total protein in the concentrate of (a) about from 0.0075:1 to 0.062:1, (b) about from 0.01:1 to 0.125:1 and (c) about from 0.05:1 1.25:1.
Claim 3
Dependent Claim 8 words
The concentrate of claim 1 which is dry.
Claim 4
Dependent Claim 18 words
The concentrate of claim 1 which additionally comprises a gamma globulin stabilizing amount of the amino acid glycine.
Claim 5
Dependent Claim 18 words
The concentrate of claim 1 wherein the macromolecule has an average molecular weight greater than about 1000 Daltons.
Claim 6
Dependent Claim 14 words
The concentrate of claim 1 wherein the macromolecule is a polyether or polyhydroxy compound.
Claim 7
Dependent Claim 13 words
The concentrate of claim 5 wherein the macromolecule is a hydrophilic vinyl polymer.
Claim 8
Dependent Claim 11 words
The concentrate of claim 5 wherein the macromolecule is a polysaccharide.
Claim 9
Dependent Claim 10 words
The concentrate of claim 7 wherein the macromolecule is polyglucose.
Claim 10
Dependent Claim 11 words
The concentrate of claim 5 wherein the macromolecule is polyethylene glycol.
Claim 11
Dependent Claim 18 words
The concentrate of claim 9 wherein the polyethylene glycol has an average molecular weight of about 4000 Daltons.
Claim 12
Dependent Claim 11 words
The concentrate of claim 1 wherein the macromolecule is substantially nonpolar.
Claim 13
Dependent Claim 24 words
The concentrate of claim 1 wherein the macromolecule is present in a ratio to total protein of about from 0.01 to 0.05 by weight.
Claim 14
Dependent Claim 12 words
The concentrate of claim 1 wherein the protein is human serum albumin.
Claim 15
Dependent Claim 24 words
The concentrate of claim 1 wherein the protein is present in a ratio to total protein of about from 0.01 to 0.05 by weight.
Claim 16
Dependent Claim 16 words
The concentrate of claim 1 wherein the polyol has a molecular weight below about 1000 Daltons.
Claim 17
Dependent Claim 15 words
The concentrate of claim 1 wherein the polyol contains less than about seven hydroxyl groups.
Claim 18
Dependent Claim 21 words
The concentrate of claim 1 wherein the polyol is a sugar, sugar alcohol or oligomer thereof containing less than four monomers.
Claim 19
Dependent Claim 12 words
The concentrate of claim 17 wherein the polyol is a nonreducing sugar.
Claim 20
Dependent Claim 10 words
The concentrate of claim 17 wherein the polyol is glucose.
Claim 21
Dependent Claim 24 words
The concentrate of claim 1 wherein the polyol is present in a ratio to total protein of about from 0.1 to 0.5 by weight.
Claim 22
Dependent Claim 11 words
The concentrate of claim 20 wherein the ratio is about 0.5.
Claim 23
Dependent Claim 24 words
The concentrate of claim 1 wherein the concentrate is in aqueous solution at a concentration of about from 40 to 100 mg gamma globulin/ml.
Claim 24
Dependent Claim 10 words
The concentrate of claim 1 in a hermetically sealed container.
Claim 25
Dependent Claim 8 words
The concentrate of claim 1 which is sterile.
Claim 26
Dependent Claim 12 words
The concentrate of claim 1 which is substantially free of nonionic surfactant.
Claim 27
Dependent Claim 18 words
The concentrate of claim 1 which is free of the block copolymer of polypropylene glycol and polyethylene glycol.
Claim 28
Dependent Claim 89 words
A stabilized gamma globulin concentrate comprising gamma globulin (a) polyethylene glycol of a molecular weight greater then about 1000 daltons, (b) a water soluble, physiologically acceptable protein other than gamma globulin and (c) a water soluble, physiologically acceptable polyol selected from the group of sugars, sugar alcohols or oligomers thereof, the polyethylene glycol, protein and polyol being present, respectively, in a weight ratio to total protein in the concentrate of (a) about from 0.0075:1 to 0.062:1, (b) about from 0.01:1 to 0.125:1 and (c) about from 0.05:1 to 1.25:1.
Claim 29
Dependent Claim 89 words
A stabilized gamma globulin concentrate comprising gamma globulin (a) polyethylene glycol of a molecular weight greater then about 1000 daltons, (b) a water soluble, physiologically acceptable protein other than gamma globulin and (c) a water soluble, physiologically acceptable polyol selected from the group of sugars, sugar alcohols or oligomers thereof, the polyethylene glycol, protein and polyol being present, respectively, in a weight ratio to total protein in the concentrate of (a) about from 0.0075:1 to 0.062:1, (b) about from 0.01:1 to 0.125:1 and (c) about from 0.05:1 to 1.25:1.

References Cited (Backward Citations)

US3966906A Cited
US3105012A Cited
US3415804A Cited
US3804754A Cited
US4089778A Cited
GB1469908A Cited
US4093606A Cited
US4126605A Cited
US4165370A Cited
US4124576A Cited
GB1597204A Cited
US4312949A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-27 1987-09-26 1988-03-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-27 1991-09-26 1992-03-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-27 1995-09-26 1996-03-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag